Biosimilars and Biobetters 2017 (description)


Address:97 Cromwell Road London, , United Kingdom SW7 4DN
Event dates:9/27/2017 - 9/28/2017 (This event has already taken place)
Event web site:
findCE GPA: This event is not yet rated. Click here to view a sample report card
Click here to rate Biosimilars and Biobetters 2017


Topics to be Covered:

  • FEATURED SPEAKERS: Bernd Liedert, Snr Clinical Program Leader Biosimilars, Boehringer Ingelheim Ho-Ung Kim, Division Head Strategy & Operations, Celltrion Healthcare Sarah Rickwood, VP, Head of European Thought Leadership, QuintilesIMS Matthew Turner, Global Medical Dir, Biosimilars, Merck Group Steiner Madsen, Medical Dir, Norwegian Medicines Agency Thomas Sachnik, Snr Manager Strategic Associate to the President & CEO Generics Europe, Teva Harish Pai, Principal Scientific Manager, Biocon Ildiko Aradi, Head Clinical Development of Biologics, Gedeon Richter Glenn Kazo, President & COO, Prolong Pharmaceuticals
  • Science, Health & Medicine, Bioethics
Organizer phone:+442078276162
Offering type:Data not provided
Specialty:Data not provided
Event frequency:Never
First Meeting:
Total events:
Est. attendance:
Target audience:Any
Other target audiences:
Host Sponsor:SMi Group
Est. # of exhibitors:
Currency:British Pounds
CE Credits:
Organizer URL


Biosimilars and Biobetters 2017 returns to London this autumn for its 8th annual show to provide the latest updates on regulation, strategies for market access and commercial success. SMi Group present the 2017 8th annual event on Biosimilars & Biobetters, taking place on 27-28 Sept in London, UK. As the patents for several innovator biologics expire, biopharmaceutical companies are taking the opportunity to develop more affordable forms creating a rapidly booming biosimilars market. However, as the field of biosimilars evolves, challenges in immunogenicity studies, securing market share, exclusivity and regulations still persist. Join us this autumn to arm yourself with the key requirements and tools for successful market entry through strategic direction on commercialisation; insight into potential therapeutic areas; and critical updates on interchangeability guidelines and patient litigation. INDUSTRY LEVERAGE: Increase speed of entry and compliance through informed guidance on interchangeability, patient litigation and IP laws Develop strategies for market access and expansion by identifying future projections Evolve clinical developments through insight into orphan drugs, in-vitro functional assays and data extrapolation Create a competitive edge through an understanding on switching studies Hear case studies on required testing such as immunogenicity and bio-similarity tests Discuss solutions in exclusivity and HCP acceptance Unique coverage of biobetters from experts in the field


Time: 8:30 am to 5:00 pm

Registration Fee Details:

Conference + 2 Workshops: GBP 2697

Conference +1 Workshop: GBP 2098

Conference Only: GBP 1499

Other items that tuition includes:

Travel and hotel arrangements:

Contact Person:Teri Arri
Organizer State/Province: (Outside US)
Organizer CountryUnited Kingdom
Organizer Phone+442078276162
Structural makeupData not provided
Host Sponsor; Other SponsorsSMi Group
Event Site/VenueHoliday Inn Kensington Forum
Event sold out?No
Multiple locations or dates?No
Statistics available for most recent event held in:NA
Average number in event attendance of:
Number in attendance of:
Target BoundariesLocal
Is Registration contact information the same as Organizer Contact above?Yes
Web Page
Can one register for your CE on your web site?NA
Can registration be made by snail (regular) mail?Yes
Online housing reservations: 
Do you have additional written or AV materials for sale?No
If so, are they available for non-attendees as well as those attending?NA
Is full tuition necessary to ensure registration?No
Will there be shuttle service available?NA

Sign In/Sign Out
About Us
Contact Us